Cowen Downgrades Synta Pharma. (SNTA) to Market Perform
Tweet Send to a Friend
Cowen downgraded Synta Pharma. (NASDAQ: SNTA) from Outperform to Market Perform.Analyst Boris Peaker commented, "In light of GALAXY-2's stoppage ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
